Search results
OneOncology's Treatment Pathways Certified by ASCO
FOX 23 News Albany· 7 hours agoOneOncology's 26 unique oncology and hematology pathways are only the fifth available pathway program reviewed and determined appropriate for use in this prestigious certification ...
Cardiff Oncology Inc [CRDF] Investment Guide: What You Need to Know – Knox Daily
Knox Daily· 1 day agoCardiff Oncology Inc’s recent filing unveils that its Director PACE GARY W acquired Company’s shares for reported $41100.0 on Dec 19 ’23. In the deal valued at $1.37 per share ...
GigaGen doses first subject in Phase I advanced solid tumour trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoGrifols subsidiary GigaGen has dosed the first subject in a Phase I clinical trial of GIGA-564, a...
How an Ohio mother's love of running got her through a cancer diagnosis and pregnancy
USA TODAY via Yahoo News· 23 minutes agoTwo weeks later, I was diagnosed.” She reached out to mutual friends to reconnect with the woman,...
Aktis to collaborate with Eli Lilly on cancer therapies
WSAU Wausau· 7 hours ago(Reuters) - Aktis Oncology said on Tuesday it will collaborate with Eli Lilly to develop cancer...
Earnings call: Predictive Oncology reports Q1 2024 financials, AI study
Investing.com· 7 days agoPredictive Oncology (Ticker: POAI) has announced its financial results for the first quarter of...
Earnings call: Predictive Oncology reports Q1 2024 financials, AI study By Investing.com
Investing.com· 6 days agoPredictive Oncology (Ticker: POAI) has announced its financial results for the first quarter of...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 9 hours agoAlthough this acquisition is expected to negatively impact earnings per share (EPS) in the current...
12 Health Care Stocks Moving In Tuesday's Intraday Session - Akanda (NASDAQ:AKAN), American Oncology...
Benzinga· 2 hours agoLosers Dare Bioscience DARE stock fell 32.8% to $0.41 during Tuesday's regular session. The company's market cap stands at $41.4 million. American Oncology Network AONC shares ...
HC Wainwright Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $28.00
ETF DAILY NEWS· 2 days agoCullinan Oncology (NASDAQ:CGEM – Free Report) had its target price decreased by HC Wainwright from $29.00 to $28.00 in a report released on Thursday morning, Benzinga reports ...
